Stoke Therapeutics, Inc. · NASDAQ:STOK
Toronto Dominion Bank reported a 5.40% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Toronto Dominion Bank reported a 5.40% stake in Stoke Therapeutics, Inc., 3,173,258 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 3,173,258
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Toronto-Dominion Bank | 5.40% | 3,173,258 |
| TD Securities Inc. | 0% | 2,300 |
Source
Related
- Stoke Therapeutics, Inc.
- Toronto Dominion Bank
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Toronto Dominion Bank · Aug 12, 2026
- Schedule 13G · Toronto Dominion Bank · Nov 14, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026